Search
implantable abdominal vagus nerve stimulator; Maestro Rechargeable System
Indications:
- treatment of obesity
- *adults >= 18 years
- *BMI of 35-45
- *>= 1 obesity-related condition (i.e. type 2 diabetes)
- *weight-loss programs have been ineffective
Procedure:
- surgically implanted into the abdomen
- implant emits electric pulses that block the vagus nerve*
* the vagus nerve signals stomach emptiness & fullness to the brain
Adverse effects:
- nausea/vomiting
- postoperative complication
Notes:
- achieves < 10% weight loss [1]
General
implant
vagus nerve stimulation (SenTiva)
References
- FDA News Release. January 14, 2015
FDA approves first-of-kind device to treat obesity
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm430223.htm